A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis
Clinical trial NCT07532486 · RECRUITING
Trial details
- NCT number
- NCT07532486
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-10
- Primary completion
- 2027-07-10
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.